|
US3853893A
(en)
*
|
1973-04-02 |
1974-12-10 |
Squibb & Sons Inc |
Anthelmintic 5-(pyridyl)-3-(isothiocyanophenyl) oxadiazoles
|
|
HU177086B
(en)
*
|
1975-06-09 |
1981-07-28 |
Eszakmagyar Vegyimuevek |
Herbicide and fungicide preparation containing substituted 1,2,4-oxadiazolidin-3-one derivatives
|
|
JPS58150576A
(ja)
*
|
1982-03-03 |
1983-09-07 |
Sumitomo Chem Co Ltd |
新規な1,2,4−オキサジアゾ−ル誘導体
|
|
DE3247118A1
(de)
*
|
1982-12-20 |
1984-06-20 |
Cassella Ag, 6000 Frankfurt |
Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
|
US6660753B2
(en)
*
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
EP1582519A3
(de)
*
|
1999-08-19 |
2005-12-21 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclische verbindungen und ihre verwendung als antagonisten von metabotropen glutamatrezeptoren
|
|
SK2512002A3
(en)
*
|
1999-08-19 |
2002-07-02 |
Nps Pharma Inc |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
KR100838447B1
(ko)
*
|
2001-02-21 |
2008-06-16 |
아스트라제네카 아베 |
헤테로폴리시클릭 화합물 및 대사향성 글루타메이트수용체 길항제로서의 그의 용도
|
|
AU2003264018A1
(en)
*
|
2002-08-09 |
2004-02-25 |
Astrazeneca Ab |
Compounds having an activity at metabotropic glutamate receptors
|
|
US8178570B2
(en)
*
|
2003-04-09 |
2012-05-15 |
Exelixis, Inc. |
Tie-2 modulators and methods of use
|
|
JP2006528980A
(ja)
*
|
2003-05-15 |
2006-12-28 |
メルク エンド カムパニー インコーポレーテッド |
S1p受容体作働薬としての3−(2−アミノ−1−アザシクロ)−5−アリール−1,2,4−オキサジアゾール類
|
|
US20060189661A1
(en)
*
|
2003-11-03 |
2006-08-24 |
Wagenen Bradford V |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
WO2005060961A2
(en)
*
|
2003-12-18 |
2005-07-07 |
Astrazeneca Ab |
Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd)
|
|
CN1898235A
(zh)
*
|
2003-12-24 |
2007-01-17 |
普罗西迪恩有限公司 |
作为gpcr受体激动剂的杂环衍生物
|
|
WO2005077368A2
(en)
*
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
EP1881979B1
(de)
*
|
2005-04-26 |
2010-08-11 |
NeuroSearch A/S |
Neuartige oxadiazol-derivate und deren medizinische verwendung
|
|
IL169855A
(en)
*
|
2005-07-25 |
2014-05-28 |
Elta Systems Ltd |
A system and method for locating a receiver location
|
|
CA2616377C
(en)
|
2005-07-26 |
2014-04-01 |
David Alexander Learmonth |
Nitrocatechol derivatives as comt inhibitors
|
|
EP1845097A1
(de)
|
2006-04-10 |
2007-10-17 |
Portela & Ca., S.A. |
Oxadiazolderivate als COMT Inihibitoren
|
|
AU2007292993B2
(en)
*
|
2006-09-07 |
2013-01-24 |
Idorsia Pharmaceuticals Ltd |
Pyridin-4-yl derivatives as immunomodulating agents
|
|
MX2009002234A
(es)
*
|
2006-09-08 |
2009-03-16 |
Actelion Pharmaceuticals Ltd |
Derivados de piridin-3-il como agentes inmunomoduladores.
|
|
EP2481410B1
(de)
|
2007-01-31 |
2016-07-13 |
BIAL - Portela & Ca., S.A. |
Catechol Derivate als COMT-Hemmer eingenommen mit einer spezifischen Dosierungsanleitung
|
|
NZ580454A
(en)
*
|
2007-03-16 |
2011-05-27 |
Actelion Pharmaceuticals Ltd |
Amino- pyridine derivatives as s1p1 /edg1 receptor agonists
|
|
PT2195311E
(pt)
*
|
2007-08-17 |
2011-05-25 |
Actelion Pharmaceuticals Ltd |
Derivados de piridina como moduladores do receptor s1p1/edg1
|
|
CN101959504A
(zh)
*
|
2008-02-28 |
2011-01-26 |
比艾尔-坡特拉有限公司 |
用于难溶性药物的药物组合物
|
|
JP5411877B2
(ja)
*
|
2008-03-06 |
2014-02-12 |
アクテリオン ファーマシューティカルズ リミテッド |
ピリジン化合物
|
|
CN102015695B
(zh)
*
|
2008-03-07 |
2014-08-27 |
埃科特莱茵药品有限公司 |
吡啶-2-基衍生物
|
|
TW200942531A
(en)
|
2008-03-17 |
2009-10-16 |
Bial Portela & Companhia S A |
Crystal forms of a nitrocatechol
|
|
AU2009258242B2
(en)
*
|
2008-05-14 |
2015-07-16 |
The Scripps Research Institute |
Novel modulators of sphingosine phosphate receptors
|
|
CN110194765A
(zh)
|
2009-02-10 |
2019-09-03 |
孟山都技术有限公司 |
用于控制线虫的组合物和方法
|
|
KR20210009441A
(ko)
|
2009-04-01 |
2021-01-26 |
바이알 - 포르텔라 앤드 씨에이 에스에이 |
니트로카테콜 유도체를 포함하는 제약 제제 및 그의 제조 방법
|
|
CN105816456A
(zh)
*
|
2009-04-01 |
2016-08-03 |
巴尔-波特拉及康邦亚股份有限公司 |
包括硝基儿茶酚衍生物的药物制剂及其制备方法
|
|
SI2454255T1
(sl)
|
2009-07-16 |
2014-01-31 |
Actelion Pharmaceuticals Ltd. |
Derivati piridin-4-ila kot agonisti s1p1/edg1
|
|
KR101869120B1
(ko)
|
2011-01-19 |
2018-06-19 |
이도르시아 파마슈티컬스 리미티드 |
2-메톡시-피리딘-4-일 유도체
|
|
US20140045900A1
(en)
|
2011-02-11 |
2014-02-13 |
Bial-Portela & Ca, S.A. |
Administration regime for nitrocatechols
|
|
PT2791134T
(pt)
|
2011-12-13 |
2019-12-18 |
BIAL PORTELA & Cª S A |
Composto químico útil como intermediário para a preparação de um inibidor de catecol-o-metiltransferase
|
|
EP2956453B1
(de)
*
|
2013-02-15 |
2019-10-02 |
Monsanto Technology LLC |
3,5-disubstituierte-4,5-dihydro-1,2,4-oxadiazole zur bekämpfung von nematodenschädlingen
|
|
JP2018500300A
(ja)
|
2014-11-28 |
2018-01-11 |
ノヴィファーマ,エス.アー. |
パーキンソン病を遅延させるための医薬
|
|
ES2770348T3
(es)
|
2015-05-20 |
2020-07-01 |
Idorsia Pharmaceuticals Ltd |
Forma cristalina del compuesto (s)-3-{4-[5-(2-ciclopentil-6-metoxi-piridin-4-il)-[1,2,4]oxadiazol-3-il]-2-etil-6-metil-fenoxi}-propano-1,2-diol
|